company background image
PHIA

Koninklijke PhilipsENXTAM:PHIA Stock Report

Last Price

€30.08

Market Cap

€25.8b

7D

-8.8%

1Y

-33.2%

Updated

16 Jan, 2022

Data

Company Financials +
PHIA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends4/6

PHIA Stock Overview

Koninklijke Philips N.V. operates as a health technology company in North America and internationally.

Koninklijke Philips Competitors

Apple

NasdaqGS:AAPL

US$2.8t

Amazon.com

NasdaqGS:AMZN

US$1.6t

Samsung Electronics

KOSE:A005930

₩521.1t

Procter & Gamble

NYSE:PG

US$386.7b

Price History & Performance

Summary of all time highs, changes and price drops for Koninklijke Philips
Historical stock prices
Current Share Price€30.08
52 Week High€50.98
52 Week Low€28.18
Beta0.80
1 Month Change-4.08%
3 Month Change-19.24%
1 Year Change-33.18%
3 Year Change-2.28%
5 Year Change9.90%
Change since IPO490.62%

Recent News & Updates

Dec 07
Is Koninklijke Philips (AMS:PHIA) Using Too Much Debt?

Is Koninklijke Philips (AMS:PHIA) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

PHIANL Medical EquipmentNL Market
7D-8.8%-6.9%0.4%
1Y-33.2%8.5%15.8%

Return vs Industry: PHIA underperformed the Dutch Medical Equipment industry which returned 8.5% over the past year.

Return vs Market: PHIA underperformed the Dutch Market which returned 15.8% over the past year.

Price Volatility

Is PHIA's price volatile compared to industry and market?
PHIA volatility
PHIA Average Weekly Movement6.5%
Medical Equipment Industry Average Movement6.7%
Market Average Movement4.4%
10% most volatile stocks in NL Market7.2%
10% least volatile stocks in NL Market2.6%

Stable Share Price: PHIA is more volatile than 75% of Dutch stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: PHIA's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Dutch stocks.

About the Company

FoundedEmployeesCEOWebsite
189177,084Frans van Houtenhttps://www.philips.com

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components, as well as integrated clinical solutions; integrated interventional systems; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.

Koninklijke Philips Fundamentals Summary

How do Koninklijke Philips's earnings and revenue compare to its market cap?
PHIA fundamental statistics
Market Cap€25.77b
Earnings (TTM)€1.17b
Revenue (TTM)€19.67b

22.0x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PHIA income statement (TTM)
Revenue€19.67b
Cost of Revenue€10.93b
Gross Profit€8.74b
Expenses€7.56b
Earnings€1.17b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Jan 24, 2022

Earnings per share (EPS)1.37
Gross Margin44.41%
Net Profit Margin5.96%
Debt/Equity Ratio65.3%

How did PHIA perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

66%

Payout Ratio

Valuation

Is Koninklijke Philips undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: PHIA (€30.08) is trading below our estimate of fair value (€94.41)

Significantly Below Fair Value: PHIA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: PHIA is good value based on its PE Ratio (22x) compared to the European Medical Equipment industry average (32.2x).

PE vs Market: PHIA is poor value based on its PE Ratio (22x) compared to the Dutch market (21.5x).


Price to Earnings Growth Ratio

PEG Ratio: PHIA's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: PHIA is good value based on its PB Ratio (2.2x) compared to the XE Medical Equipment industry average (4.6x).


Future Growth

How is Koninklijke Philips forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?

-7.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PHIA's earnings are forecast to decline over the next 3 years (-7.2% per year).

Earnings vs Market: PHIA's earnings are forecast to decline over the next 3 years (-7.2% per year).

High Growth Earnings: PHIA's earnings are forecast to decline over the next 3 years.

Revenue vs Market: PHIA's revenue (5.3% per year) is forecast to grow slower than the Dutch market (8.8% per year).

High Growth Revenue: PHIA's revenue (5.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PHIA's Return on Equity is forecast to be low in 3 years time (13.6%).


Past Performance

How has Koninklijke Philips performed over the past 5 years?

9.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PHIA has high quality earnings.

Growing Profit Margin: PHIA's current net profit margins (6%) are higher than last year (5.9%).


Past Earnings Growth Analysis

Earnings Trend: PHIA's earnings have grown by 9.8% per year over the past 5 years.

Accelerating Growth: PHIA's earnings growth over the past year (2.7%) is below its 5-year average (9.8% per year).

Earnings vs Industry: PHIA earnings growth over the past year (2.7%) underperformed the Medical Equipment industry 62.2%.


Return on Equity

High ROE: PHIA's Return on Equity (9.9%) is considered low.


Financial Health

How is Koninklijke Philips's financial position?


Financial Position Analysis

Short Term Liabilities: PHIA's short term assets (€9.4B) exceed its short term liabilities (€8.8B).

Long Term Liabilities: PHIA's short term assets (€9.4B) exceed its long term liabilities (€8.2B).


Debt to Equity History and Analysis

Debt Level: PHIA's net debt to equity ratio (57%) is considered high.

Reducing Debt: PHIA's debt to equity ratio has increased from 44.3% to 65.3% over the past 5 years.

Debt Coverage: PHIA's debt is well covered by operating cash flow (35.4%).

Interest Coverage: PHIA's interest payments on its debt are well covered by EBIT (12.2x coverage).


Balance Sheet


Dividend

What is Koninklijke Philips's current dividend yield, its reliability and sustainability?

2.83%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: PHIA's dividend (2.83%) is higher than the bottom 25% of dividend payers in the Dutch market (1.55%).

High Dividend: PHIA's dividend (2.83%) is low compared to the top 25% of dividend payers in the Dutch market (4.19%).


Stability and Growth of Payments

Stable Dividend: PHIA's dividend payments have been volatile in the past 10 years.

Growing Dividend: PHIA's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (65.8%), PHIA's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: PHIA's dividends in 3 years are forecast to be well covered by earnings (45.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.0yrs

Average management tenure


CEO

Frans van Houten (61 yo)

10.75yrs

Tenure

€6,153,066

Compensation

Mr. François Adrianus van Houten, also known as Frans, has been the Chief Executive Officer and Chairman of Management Board of Royal Philips at Philips India Limited since April 2011. Mr. van Houten serve...


CEO Compensation Analysis

Compensation vs Market: Frans's total compensation ($USD7.03M) is above average for companies of similar size in the Dutch market ($USD3.01M).

Compensation vs Earnings: Frans's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: PHIA's management team is seasoned and experienced (6 years average tenure).


Board Members

Experienced Board: PHIA's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Koninklijke Philips N.V.'s employee growth, exchange listings and data sources


Key Information

  • Name: Koninklijke Philips N.V.
  • Ticker: PHIA
  • Exchange: ENXTAM
  • Founded: 1891
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: €25.766b
  • Shares outstanding: 856.72m
  • Website: https://www.philips.com

Number of Employees


Location

  • Koninklijke Philips N.V.
  • Philips Center
  • Amstelplein 2
  • Amsterdam
  • Noord-Holland
  • 1096 BC
  • Netherlands

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/16 19:05
End of Day Share Price2022/01/14 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.